1. Home
  2. GORO vs GNLX Comparison

GORO vs GNLX Comparison

Compare GORO & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.60

Market Cap

194.1M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.70

Market Cap

202.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
GNLX
Founded
1998
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.1M
202.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
GORO
GNLX
Price
$1.60
$2.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$1.75
$19.75
AVG Volume (30 Days)
11.7M
377.8K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,430,000.00
N/A
Revenue This Year
$8.76
N/A
Revenue Next Year
$85.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$1.99
52 Week High
$1.87
$8.54

Technical Indicators

Market Signals
Indicator
GORO
GNLX
Relative Strength Index (RSI) 65.74 32.48
Support Level $0.95 $2.75
Resistance Level $1.87 $2.97
Average True Range (ATR) 0.21 0.20
MACD 0.06 0.06
Stochastic Oscillator 71.37 36.06

Price Performance

Historical Comparison
GORO
GNLX

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: